Latest filing published 29 Jun 2009 for CORCEPT THERAPEUTICS INC.
Insider track record
No signal scores available.
Closed purchases
Based on 26 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -67.1%Entry US$3.22 · Close at T+365 US$1.06
- -60.8%Entry US$2.55 · Close at T+365 US$1.00
- -59.9%Entry US$2.74 · Close at T+365 US$1.10
- -65.9%Entry US$2.99 · Close at T+365 US$1.02
- -55.1%Entry US$2.92 · Close at T+365 US$1.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Allen Andersson: trading record in brief
Allen Andersson is a declared insider of Corcept Therapeutics Inc, with filings sourced from SEC (Form 4). Between 17 August 2007 and 7 May 2009, the trades on record add up to 71 filings.
The open-market side counts 57 purchases for €8.3M alongside 11 sales for €6.3M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. 2009 to date brings no purchases and 11 sales.
A typical purchase (the median) is worth €19k. Looking at 26 purchases old enough to measure, the stock rose over the following 90 days in 19% of cases; the median change was -8.4%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 29 June 2009 with a transaction in Corcept Therapeutics Inc. The last insider purchase was made public on 21 November 2008, 6,561 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Allen Andersson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 152,570 shares0Common StockSEC:0001209191-09-033940:0
- 47,430 shares@ US$0.855Common StockSEC:0001209191-09-033940:1
- 47,857 shares@ US$1.00Common StockSEC:0001209191-09-022070:0
- 90,000 shares@ US$1.00Common StockSEC:0001209191-09-022070:1
- 200,000 shares0Common StockSEC:0001209191-09-015537:0
- 60,000 shares@ US$0.70Common StockSEC:0001209191-09-010552:0
- 142,857 shares@ US$0.70Common StockSEC:0001209191-09-010552:1
- 9,910,270 shares@ US$0.687Common StockSEC:0001209191-09-007982:0
- 285,714 shares@ US$0.70Common StockSEC:0001209191-09-007982:1
- 285,714 shares@ US$0.70Common StockSEC:0001209191-09-007982:2
- 432,809 shares@ US$0.70Common StockSEC:0001209191-09-007982:3
- 584,763 sharesCommon StockSEC:0001209191-08-062125:0Canonical exit: 17 Feb 2009 (T+90)
- 209,655 shares@ US$1.45Common StockSEC:0001209191-08-060557:0
- 2,118,270 shares@ US$2.77Common StockSEC:0001209191-08-020579:0Canonical exit: 23 Jun 2008 (T+90)
- 5,000 shares@ US$2.61Common StockSEC:0001209191-08-005444:0Canonical exit: 15 Apr 2008 (T+90)
- 5,000 shares@ US$2.74Common StockSEC:0001209191-08-005444:1Canonical exit: 16 Apr 2008 (T+90)
- 5,500 shares@ US$2.63Common StockSEC:0001209191-08-005444:2Canonical exit: 17 Apr 2008 (T+90)
- 17,000 shares@ US$2.56Common StockSEC:0001209191-08-005444:3Canonical exit: 21 Apr 2008 (T+90)
- 5,000 shares@ US$2.61Common StockSEC:0001209191-08-005444:4Canonical exit: 22 Apr 2008 (T+90)
- 7,556 shares@ US$2.95Common StockSEC:0001209191-07-068670:0Canonical exit: 24 Feb 2008 (T+90)
- 4,444 shares@ US$2.93Common StockSEC:0001209191-07-068670:1Canonical exit: 25 Feb 2008 (T+90)
- 8,617 shares@ US$3.01Common StockSEC:0001209191-07-068670:2Canonical exit: 26 Feb 2008 (T+90)
- 5,000 shares@ US$3.00Common StockSEC:0001209191-07-068670:3Canonical exit: 27 Feb 2008 (T+90)
- 5,000 shares@ US$2.98Common StockSEC:0001209191-07-068670:4Canonical exit: 28 Feb 2008 (T+90)
- 5,000 shares@ US$2.90Common StockSEC:0001209191-07-068670:5Canonical exit: 2 Mar 2008 (T+90)
25 of 39 declarations
